Skip to main content
logo
Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
8.19
+0.63 (8.33%)
At close: Oct 9, 2026, 4:00 PM EDT
8.30
+0.11 (1.34%)
Pre-market: Oct 12, 2026, 5:59 AM EDT

Immunic Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-117.88-103.23-98.05-99.22-86.52-74.42
Net Income
-111.57-97.17-100.51-93.61-120.41-92.95
Earnings Per Share
-4.00-6.24-10.03-21.12-37.84-39.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
155.115.4835.6746.67116.3786.86
Total Debt
0.570.5811.331.560.99
Net Cash (Debt)
154.5314.9134.6645.34114.8185.87
Net Cash Growth
184.42%-57.00%-23.55%-60.51%33.70%-32.10%
Net Cash Per Share
5.540.963.4610.2336.0836.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-87.72-85.81-84.77-70.83-65.14-83.23
Capital Expenditures
-0.33-0.16-0.26-0.33-0.11-0.07
Free Cash Flow
-88.05-85.97-85.03-71.16-65.26-83.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Selected indicators aren't available for this stock.